Sentinel-node technique will change the design of clinical trials in malignant melanoma
- PMID: 11956283
- DOI: 10.1200/JCO.2002.20.8.2208
Sentinel-node technique will change the design of clinical trials in malignant melanoma
Comment on
-
High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801.J Clin Oncol. 2001 May 1;19(9):2370-80. doi: 10.1200/JCO.2001.19.9.2370. J Clin Oncol. 2001. PMID: 11331315 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
